Colorectal cancer is a common malignant tumor of the digestive tract, mainly occurring in people over 50 years old. It progresses rapidly, and without timely treatment, cancer cells may spread to other organs, causing severe complications and significantly reducing survival rates. Current treatments are based on multidisciplinary comprehensive strategies, emphasizing early diagnosis and personalized approaches, with the goal of controlling the disease, prolonging survival, and improving quality of life.
Immune reconstruction cell therapy enhances and activates the patient’s own immune system to help identify and eliminate cancer cells, significantly improving treatment outcomes.
① Activates immune cells and increases tumor cell-killing capacity;
② Reduces side effects from chemotherapy and radiotherapy, improving overall tolerance;
③ Suitable for advanced and recurrent patients, improving quality of life and survival.
In practice, cancer patients undergoing surgery, chemotherapy, or radiotherapy often experience impaired immune function, increased risk of infection, and slow recovery. To better support patients throughout the treatment process, improve tolerance, and enhance survival quality, phased and scientifically designed immune reconstruction plans are required.
● Short-term plan: Rapidly boost immunity through immune cell transfusion to strengthen anti-tumor treatment.
● Mid-term plan: Reduce side effects of conventional treatments, promote recovery, and complete standard therapies.
● Long-term plan: Comprehensive immune enhancement through immune cell reconstruction, intestinal immune rebuilding, elemental immune rebuilding, and immune nutrition rebuilding, thereby improving quality of life and extending survival.
1. Surgical treatment
Surgical resection remains the main curative method for colorectal cancer, especially for early-stage patients. With medical advancements, laparoscopic and other minimally invasive techniques are increasingly used, offering advantages such as smaller trauma, faster recovery, and fewer postoperative complications, providing a better treatment experience.
2. Radiotherapy
Radiotherapy is commonly used as an adjuvant treatment for rectal cancer to effectively reduce the risk of local recurrence. Advanced technologies such as intensity-modulated radiotherapy improve precision, maximize protection of normal tissues, and minimize side effects.
3. Chemotherapy
Chemotherapy is suitable for postoperative adjuvant therapy and advanced patients. Common drugs include fluorouracil and oxaliplatin. Combined with targeted drugs, chemotherapy can enhance overall efficacy and delay disease progression.
4. Targeted therapy
Targeted therapy focuses on specific molecular markers of cancer cells, blocking growth signals and inhibiting tumor progression. It is suitable for patients with specific genetic mutations and is usually combined with chemotherapy to improve outcomes.
5. Minimally invasive treatment
Minimally invasive approaches such as endoscopic tumor resection and radiofrequency ablation offer less invasive, faster recovery options for some early-stage patients. These techniques are gradually being applied in clinical practice to improve patient experience.
Colorectal cancer treatment requires the integration of multiple approaches, combining immune reconstruction cell therapy with traditional methods to achieve personalized treatment. Experts from United Life International Medical Center emphasize that early diagnosis and active treatment are key to improving survival and quality of life. Patients should follow professional medical guidance to manage the condition scientifically and strive for the best treatment outcomes.